ニュース NEWS
AIK
-
Mami Hino, Naho Ebata and Shoichiro Kajnami co-authored an article titled “Japan: Sawai’s Generic Drug is approved by the MHLW amid patent litigation with Bristol-Myers Squibb, but the Court orders preliminary injunction against Sawai soon after” posted on Kluwer Patent Blog.
-
Hirotatsu Taura joined the firm
-
Naho Ebata gave a presentation titled “Recent IP Developments in Japan” at 2023 AIPPI Trilateral Meeting held in Qingdao, China.
-
Eiji Katayama, Makoto Hattori, Shimako Kato, Emiko Maki and Chitaka Iwama gave presentations at the IP seminar jointly hosted by our firm and Lee & Ko (Korea).
-
Shoichiro Kajinami authored an article titled “Case re. Publicly Practiced Invention by Only Exhibition” posted on AIPPI Japan Journal Vol.68 No.5 (May 2023).
-
Shoichiro Kajinami participated as a panelist at “AI and Data-Driven IP.”
-
Mami Hino and Naho Ebata co-authored an article titled “Amgen v. Sanofi and Regeneron: Japan IP High Court overrules its own decision on validity of Amgen patent” posted on Kluwer Patent Blog.
-
Shimako Kato gave a presentation titled “The Japanese Approach to an Extraterritorial Infringement” at 30th Annual Fordham IP Conference.
-
Serina Matsuda was appointed as a member of Japanese Fair Trade Commission (JFTC), The Study Group on Innovation and Competition Policy
-
Shoichiro Kajinami participated as a panelist at the 20th Open Forum “Prior User’s Right – Major Issues in the Debate” hosted by the Japan Patent Attorneys Association, Central Research Institute of Intellectual Property.